KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 119 filers reported holding KALVISTA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.17 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $114,395 | +35.4% | 11,879 | +26.5% | 0.00% | – |
| Q2 2023 | $84,483 | -28.9% | 9,387 | -37.9% | 0.00% | – |
| Q1 2023 | $118,867 | +69.1% | 15,123 | +45.4% | 0.00% | – |
| Q4 2022 | $70,304 | -52.8% | 10,400 | +1.6% | 0.00% | – |
| Q3 2022 | $149,000 | +41.9% | 10,238 | -3.7% | 0.00% | – |
| Q2 2022 | $105,000 | -44.4% | 10,633 | -17.3% | 0.00% | – |
| Q1 2022 | $189,000 | +1.6% | 12,852 | -8.7% | 0.00% | – |
| Q4 2021 | $186,000 | -32.1% | 14,078 | -10.4% | 0.00% | – |
| Q3 2021 | $274,000 | -5.2% | 15,708 | +29.9% | 0.00% | – |
| Q2 2021 | $289,000 | -9.7% | 12,091 | -3.1% | 0.00% | – |
| Q1 2021 | $320,000 | +57.6% | 12,475 | +16.5% | 0.00% | – |
| Q4 2020 | $203,000 | +113.7% | 10,712 | +41.0% | 0.00% | – |
| Q3 2020 | $95,000 | +15.9% | 7,596 | +12.6% | 0.00% | – |
| Q2 2020 | $82,000 | +148.5% | 6,747 | +55.6% | 0.00% | – |
| Q1 2020 | $33,000 | -59.3% | 4,336 | -5.7% | 0.00% | – |
| Q4 2019 | $81,000 | -19.8% | 4,598 | -47.5% | 0.00% | – |
| Q3 2019 | $101,000 | -50.5% | 8,757 | -5.7% | 0.00% | – |
| Q2 2019 | $204,000 | -59.8% | 9,286 | -47.8% | 0.00% | – |
| Q1 2019 | $508,000 | +16833.3% | 17,787 | +10424.9% | 0.00% | – |
| Q4 2018 | $3,000 | -99.2% | 169 | -99.0% | 0.00% | – |
| Q3 2018 | $358,000 | -12.5% | 16,187 | -67.9% | 0.00% | – |
| Q2 2018 | $409,000 | 0.0% | 50,461 | +16.7% | 0.00% | – |
| Q1 2018 | $409,000 | -50.1% | 43,245 | -48.5% | 0.00% | -100.0% |
| Q4 2017 | $819,000 | – | 84,004 | +1679980.0% | 0.00% | – |
| Q3 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 5 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Saturn V Capital Management LP | 1,810,246 | $17,432,669 | 7.30% |
| TCG Crossover Management, LLC | 3,395,495 | $32,698,617 | 4.82% |
| TANG CAPITAL MANAGEMENT LLC | 3,440,345 | $33,130,522 | 4.68% |
| VR Adviser, LLC | 2,916,667 | $28,087,503 | 2.96% |
| Frazier Life Sciences Management, L.P. | 3,238,859 | $31,190,212 | 2.07% |
| Nan Fung Group Holdings Ltd | 234,573 | $2,258,938 | 1.83% |
| DAFNA Capital Management LLC | 605,532 | $5,831,273 | 1.81% |
| Opaleye Management Inc. | 500,000 | $4,815,000 | 1.57% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 530,400 | $5,107,752 | 1.55% |
| MPM BioImpact LLC | 577,958 | $5,565,736 | 1.49% |